December 15, 2008, Teaneck, NJ. DFW Capital Partners announced today that its portfolio company, Alaven Pharmaceutical, has acquired the assets of DrNatura, a leading web-based direct-to-consumer marketer of colon and digestive health products. As part of the transaction, Alaven created a separate subsidiary, Alaven Consumer Health, to house DrNatura and Alaven’s other OTC Alaven products.… Read more »
DFW Capital Partners announced today that it has led the acquisition of a majority interest in The Copernicus Group IRB, from its founding owners. DFW recruited pharmaceutical industry veteran, Bruce Tomason, to become CEO of Copernicus and lead the business post-acquisition. DFW completed this investment, in part, with funds from its most recent private equity… Read more »
DFW Capital Partners announced today that it has completed the sale of its portfolio company, Andrews International, to Boston-based private equity firm Audax Group for an aggregate purchase price of $161 million. DFW realized a 30% IRR and a 2.6x ROI on its investment in Andrews. DFW originally invested in Andrews’ predecessor company in 2004,… Read more »
DFW Capital Partners announced today that it has completed the sale of its portfolio company, ConsoliDent to Great Expressions Dental, a portfolio company of Audax Group. DFW realized a 2.2x aggregate ROI on its investment in ConsoliDent. DFW originally invested in ConsoliDent, a leading regional dental practice management company, in 1998, as the company established… Read more »